{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:14:27Z","timestamp":1777479267572,"version":"3.51.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.reprotox.2025.108862","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T07:28:54Z","timestamp":1739777334000},"page":"108862","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Antidepressant aripiprazole induces adverse effects on neural development during cortex organoid generation"],"prefix":"10.1016","volume":"133","author":[{"given":"Youngin","family":"Jeong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suil","family":"Son","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C-Yoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5484-380X","authenticated-orcid":false,"given":"Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.reprotox.2025.108862_bib1","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/acps.12042","article-title":"Antidepressant use in pregnancy: a critical review focused on risks and controversies","volume":"127","author":"Byatt","year":"2013","journal-title":"Acta Psychiatr. Scand."},{"issue":"7","key":"10.1016\/j.reprotox.2025.108862_bib2","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1001\/archpsyc.65.7.805","article-title":"Psychiatric disorders in pregnant and postpartum women in the United States","volume":"65","author":"Vesga-Lopez","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"issue":"4","key":"10.1016\/j.reprotox.2025.108862_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph21040404","article-title":"Depression treatment in pregnancy: is it safe, or is it not?","volume":"21","author":"Gallitelli","year":"2024","journal-title":"Int J. Environ. Res Public Health"},{"issue":"6","key":"10.1016\/j.reprotox.2025.108862_bib4","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00737-016-0637-1","article-title":"Use of selective serotonin reuptake inhibitors (SSRIs) in women delivering liveborn infants and other women of child-bearing age within the U.S. Food and Drug Administration's Mini-Sentinel program","volume":"19","author":"Andrade","year":"2016","journal-title":"Arch. Women\u2019s. Ment. Health"},{"issue":"5","key":"10.1016\/j.reprotox.2025.108862_bib5","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1176\/appi.ajp.160.5.993","article-title":"Placental passage of antidepressant medications","volume":"160","author":"Hendrick","year":"2003","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.reprotox.2025.108862_bib6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s44294-024-00008-0","article-title":"Antidepressant use during pregnancy and the risk of preterm birth\u2013a cohort study","volume":"2","author":"Amit","year":"2024","journal-title":"npj Women'S. Health"},{"issue":"11","key":"10.1016\/j.reprotox.2025.108862_bib7","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1001\/archgenpsychiatry.2011.73","article-title":"Antidepressant use during pregnancy and childhood autism spectrum disorders","volume":"68","author":"Croen","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.reprotox.2025.108862_bib8","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/JCP.0000000000000868","article-title":"Maternal antidepressant use during pregnancy and the risk of attention-deficit\/hyperactivity disorder in children: a systematic review of the current literature","volume":"38","author":"Uguz","year":"2018","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.reprotox.2025.108862_bib9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.pscychresns.2016.05.004","article-title":"Antenatal depression, treatment with selective serotonin reuptake inhibitors, and neonatal brain structure: a propensity-matched cohort study","volume":"253","author":"Jha","year":"2016","journal-title":"Psychiatr. Res. Neuroimaging"},{"issue":"11","key":"10.1016\/j.reprotox.2025.108862_bib10","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1176\/appi.ps.201600408","article-title":"Antipsychotic medication use among publicly insured pregnant women in the United States","volume":"68","author":"Park","year":"2017","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.reprotox.2025.108862_bib11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jad.2017.12.021","article-title":"Aripiprazole use during pregnancy, peripartum and lactation. A systematic literature search and review to inform clinical practice","volume":"228","author":"Cuomo","year":"2018","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.reprotox.2025.108862_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2024.117009","article-title":"Effect of aripiprazole on neural tube development in early chick embryos","volume":"489","author":"Gursoy","year":"2024","journal-title":"Toxicol. Appl. Pharm."},{"key":"10.1016\/j.reprotox.2025.108862_bib13","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jad.2018.06.004","article-title":"Aripiprazole and pregnancy: a retrospective, multicentre study","volume":"238","author":"Galbally","year":"2018","journal-title":"J. Affect Disord."},{"issue":"4","key":"10.1016\/j.reprotox.2025.108862_bib14","first-page":"1091","article-title":"Teratogenic potential of commonly prescribed psychotropic drugs","volume":"4","author":"Ahmed","year":"2016","journal-title":"Med J. Obstet. Gynecol."},{"key":"10.1016\/j.reprotox.2025.108862_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2023.01.016","article-title":"Availability of safe and effective therapeutic options to pregnant and lactating individuals following the United States food and drug administration pregnancy and lactation labeling rule","volume":"259","author":"Patel","year":"2023","journal-title":"J. Pedia"},{"issue":"4","key":"10.1016\/j.reprotox.2025.108862_bib16","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10735-024-10199-0","article-title":"Prenatal aripiprazole induces alterations of rat placenta: a histological, immunohistochemical and ultrastructural study","volume":"55","author":"Othman","year":"2024","journal-title":"J. Mol. Histol."},{"issue":"10","key":"10.1016\/j.reprotox.2025.108862_bib17","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/aps.2011.77","article-title":"Neurobehavioral and genotoxic parameters of antipsychotic agent aripiprazole in mice","volume":"32","author":"Picada","year":"2011","journal-title":"Acta Pharm. Sin."},{"issue":"8","key":"10.1016\/j.reprotox.2025.108862_bib18","doi-asserted-by":"crossref","DOI":"10.1242\/dev.166074","article-title":"Brain organoids: advances, applications and challenges","volume":"146","author":"Qian","year":"2019","journal-title":"Development"},{"key":"10.1016\/j.reprotox.2025.108862_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2024.1351734","article-title":"Brain organoid protocols and limitations","volume":"18","author":"Zhao","year":"2024","journal-title":"Front Cell Neurosci."},{"issue":"1","key":"10.1016\/j.reprotox.2025.108862_bib20","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/s41398-022-02279-0","article-title":"Benchmarking brain organoid recapitulation of fetal corticogenesis","volume":"12","author":"Cheroni","year":"2022","journal-title":"Transl. Psychiatry"},{"issue":"51","key":"10.1016\/j.reprotox.2025.108862_bib21","doi-asserted-by":"crossref","first-page":"15672","DOI":"10.1073\/pnas.1520760112","article-title":"Human cerebral organoids recapitulate gene expression programs of fetal neocortex development","volume":"112","author":"Camp","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.reprotox.2025.108862_bib22","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1016\/j.celrep.2016.12.001","article-title":"Cerebral organoids recapitulate epigenomic signatures of the human fetal brain","volume":"17","author":"Luo","year":"2016","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.reprotox.2025.108862_bib23","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.stem.2019.08.002","article-title":"Complex oscillatory waves emerging from cortical organoids model early human brain network development","volume":"25","author":"Trujillo","year":"2019","journal-title":"Cell Stem Cell"},{"issue":"4","key":"10.1016\/j.reprotox.2025.108862_bib24","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s40263-023-00996-8","article-title":"A randomized, open-label, multiple-dose, parallel-arm, pivotal study to evaluate the safety, tolerability, and pharmacokinetics of aripiprazole 2-month long-acting injectable in adults with schizophrenia or bipolar I disorder","volume":"37","author":"Harlin","year":"2023","journal-title":"CNS Drugs"},{"key":"10.1016\/j.reprotox.2025.108862_bib25","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.2147\/NDT.S143337","article-title":"Long-acting formulations delivering aripiprazole: beyond single-value characterizations of steady-state pharmacokinetics","volume":"13","author":"McConnell","year":"2017","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"5","key":"10.1016\/j.reprotox.2025.108862_bib26","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/JCP.0000000000000921","article-title":"Pharmacokinetic evaluation of a 1-day treatment initiation option for starting long-acting aripiprazole lauroxil for schizophrenia","volume":"38","author":"Hard","year":"2018","journal-title":"J. Clin. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.reprotox.2025.108862_bib27","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.3415","article-title":"Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture","volume":"12","author":"Pasca","year":"2015","journal-title":"Nat. Methods"},{"issue":"8","key":"10.1016\/j.reprotox.2025.108862_bib28","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00406-011-0201-y","article-title":"Clomipramine-induced serum prolactin as a marker for serotonin and dopamine turnover: results of an open label study","volume":"261","author":"Cordes","year":"2011","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"8032","key":"10.1016\/j.reprotox.2025.108862_bib29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0140-6736(77)90956-4","article-title":"Elevation of plasma-prolactin by monoamine-oxidase inhibitors","author":"Slater","year":"1977","journal-title":"Lancet 2"},{"key":"10.1016\/j.reprotox.2025.108862_bib30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0002-9378(91)90645-8","article-title":"A selective serotonin reuptake inhibitor, fluoxetine hydrochloride, modulates the pulsatile release of prolactin in postmenopausal women","volume":"164","author":"Urban","year":"1991","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.reprotox.2025.108862_bib31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s40290-023-00462-2","article-title":"Clinical presentations of drug-induced hyperprolactinaemia: a literature review","volume":"37","author":"Junqueira","year":"2023","journal-title":"Pharm. Med"},{"issue":"1","key":"10.1016\/j.reprotox.2025.108862_bib32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4103\/IJPSYM.IJPSYM_147_17","article-title":"Add-on aripiprazole for atypical antipsychotic-induced, clinically significant hyperprolactinemia","volume":"40","author":"Raveendranthan","year":"2018","journal-title":"Indian J. Psychol. Med"},{"issue":"2","key":"10.1016\/j.reprotox.2025.108862_bib33","first-page":"133","article-title":"Safety profile of aripiprazole during pregnancy and lactation: report of 2 cases","volume":"34","author":"Sahoo","year":"2023","journal-title":"Turk. Psikiyatr. Derg."},{"issue":"5","key":"10.1016\/j.reprotox.2025.108862_bib34","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1001\/jamainternmed.2022.0375","article-title":"Association of antipsychotic drug exposure in pregnancy with risk of neurodevelopmental disorders: a national birth cohort study","volume":"182","author":"Straub","year":"2022","journal-title":"JAMA Intern Med"},{"issue":"1-02","key":"10.1016\/j.reprotox.2025.108862_bib35","first-page":"9","article-title":"Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017","volume":"51","author":"Hiemke","year":"2018","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"10.1016\/j.reprotox.2025.108862_bib36","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/0091270003261901","article-title":"Pharmacokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in normal healthy volunteers","volume":"44","author":"Mallikaarjun","year":"2004","journal-title":"J. Clin. Pharm."},{"issue":"11","key":"10.1016\/j.reprotox.2025.108862_bib37","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/s41582-022-00723-9","article-title":"Human cerebral organoids - a new tool for clinical neurology research","volume":"18","author":"Eichmuller","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.reprotox.2025.108862_bib38","doi-asserted-by":"crossref","first-page":"15045","DOI":"10.1038\/celldisc.2015.45","article-title":"Mapping gene regulatory circuitry of Pax6 during neurogenesis","volume":"2","author":"Thakurela","year":"2016","journal-title":"Cell Discov."},{"issue":"12","key":"10.1016\/j.reprotox.2025.108862_bib39","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1007\/s00018-018-2794-z","article-title":"Nestin-expressing progenitor cells: function, identity and therapeutic implications","volume":"75","author":"Bernal","year":"2018","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.reprotox.2025.108862_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.594090","article-title":"Simplified brain organoids for rapid and robust modeling of brain disease","volume":"8","author":"Ha","year":"2020","journal-title":"Front Cell Dev. Biol."},{"issue":"10","key":"10.1016\/j.reprotox.2025.108862_bib41","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrn.2017.107","article-title":"The use of brain organoids to investigate neural development and disease","volume":"18","author":"Di Lullo","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.reprotox.2025.108862_bib42","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s13287-023-03454-w","article-title":"Effects of dopamine on stem cells and its potential roles in the treatment of inflammatory disorders: a narrative review","volume":"14","author":"Liu","year":"2023","journal-title":"Stem Cell Res Ther."},{"issue":"9","key":"10.1016\/j.reprotox.2025.108862_bib43","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1523\/JNEUROSCI.3574-07.2008","article-title":"Ciliary neurotrophic factor mediates dopamine D2 receptor-induced CNS neurogenesis in adult mice","volume":"28","author":"Yang","year":"2008","journal-title":"J. Neurosci."},{"issue":"24","key":"10.1016\/j.reprotox.2025.108862_bib44","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.1523\/JNEUROSCI.1120-05.2005","article-title":"D. van der Kooy, Dopamine specifically inhibits forebrain neural stem cell proliferation, suggesting a novel effect of antipsychotic drugs","volume":"25","author":"Kippin","year":"2005","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.reprotox.2025.108862_bib45","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/sj.npp.1300320","article-title":"Serotonin-induced increases in adult cell proliferation and neurogenesis are mediated through different and common 5-HT receptor subtypes in the dentate gyrus and the subventricular zone","volume":"29","author":"Banasr","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.reprotox.2025.108862_bib46","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/npp.2011.194","article-title":"Placental source for 5-HT that tunes fetal brain development","volume":"37","author":"Bonnin","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.reprotox.2025.108862_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2022.136447","article-title":"Fluoxetine regulates the neuronal differentiation of neural stem cells transplanted into rat brains after stroke by increasing the 5HT level","volume":"772","author":"Wei","year":"2022","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.reprotox.2025.108862_bib48","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.stemcr.2020.08.017","article-title":"Electrophysiological maturation of cerebral organoids correlates with dynamic morphological and cellular development","volume":"15","author":"Fair","year":"2020","journal-title":"Stem Cell Rep."},{"issue":"1","key":"10.1016\/j.reprotox.2025.108862_bib49","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41398-022-01898-x","article-title":"Human forebrain organoids reveal connections between valproic acid exposure and autism risk","volume":"12","author":"Meng","year":"2022","journal-title":"Transl. Psychiatry"},{"issue":"6","key":"10.1016\/j.reprotox.2025.108862_bib50","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/mp.2016.95","article-title":"Altered proliferation and networks in neural cells derived from idiopathic autistic individuals","volume":"22","author":"Marchetto","year":"2017","journal-title":"Mol. Psychiatry"},{"issue":"47","key":"10.1016\/j.reprotox.2025.108862_bib51","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adf2772","article-title":"Neurodevelopmental defects in human cortical organoids with N-acetylneuraminic acid synthase mutation","volume":"9","author":"Bu","year":"2023","journal-title":"Sci. Adv."}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623825000334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623825000334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T02:17:13Z","timestamp":1741918633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890623825000334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":51,"alternative-id":["S0890623825000334"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2025.108862","relation":{},"ISSN":["0890-6238"],"issn-type":[{"value":"0890-6238","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antidepressant aripiprazole induces adverse effects on neural development during cortex organoid generation","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2025.108862","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108862"}}